Clinical Trials Sponsored by Ken Marek, MD

Total 91 results

Ken Marek, MD
Institute for Neurodegenerative Disorders

Completed

Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression (PPMI)

Parkinson Disease

United States, Spain, Israel, Norway, Germany, Italy, United Kingdom, France, Austria, Australia, Greece
Mark Mofid MD
Allergan

Completed

Circumferential Periareolar Mastopexy Using SERI Surgical Scaffold

Mastopexy

United States
Tarek A Abdelsalam, MD

Completed

Evaluation of Oral and Maxillofacial Swellings by Ultrasonographic Features (Research)

Swelling Lips & Face

Egypt
Schmidhofer, Mark, MD

Completed

Inhaled Nitrite in Subjects With Pulmonary Hypertension

Pulmonary Hypertension | Heart Failure, Diastolic

United States
Gladwin, Mark, MD

Withdrawn

Oral Nitrite Trial for Hypertension and Metabolic Syndrome (ONPC)

Hypertension | Metabolic Syndrome

United States
Gladwin, Mark, MD

Completed

Oral Nitrite in Adults With Metabolic Syndrome and Hypertension (ONTX)

Hypertension | Metabolic Syndrome

United States
Gladwin, Mark, MD

Completed

Oral Nitrite and Nitrate in Healthy Normal Volunteer Adults

Focus of Study of Healthy Adults

United States
Gladwin, Mark, MD

Completed

The Effects of NOx and Conjugated Linoleic Acid on Asthmatics (NICLA)

Asthma

United States
Gladwin, Mark, MD

Completed

Oral Nitrite for Older Heart Failure Patients (ONTx+HF)

Heart Failure

United States
Gladwin, Mark, MD

Terminated

Sodium Nitrite in Lung Transplant Patients to Minimize the Risk of Pulmonary Graft Dysfunction

Primary Graft Dysfunction

United States
Gladwin, Mark, MD

Terminated

Endothelial Injury and Development of Coronary Intimal Thickening After Heart Transplantation

Cardiac Allograft Vasculopathy | Antibody Mediated Rejection

United States
Mark Gallardo, MD

Unknown

A Single Center Proof Of Concept Study To Assess Intra And Perioperative Safety Profile Of OMNI Surgical System

Open Angle Glaucoma

United States
Mark Weiser, MD, Principal Investigator

Active, not recruiting

Side Effects of Psychiatric Medications - a Nested Case Control Cohort Historical Prospective Study

Psychotic Disorders

Israel
Mark M. Fuster, MD

Withdrawn

Early Diagnosis and Treatment of Sleep Disordered Breathing in Lung Cancer

Lung Cancer

United States
NBTY, Inc.
KGK Science Inc.; Moyad, Mark MD MPH

Completed

Tolerance of Two Forms of Vitamin C in Acid-sensitive Adults

Tolerance

Canada
NBTY, Inc.
KGK Science Inc.; Moyad, Mark MD MPH

Completed

Comparative Bioavailability of Two Forms of Vitamin C

Bioavailability

Canada
Mark Packer, MD, FACS

Completed

Selection of Aspheric Diffractive Multifocal Intraocular Lens (IOLS) Based on Corneal Wavefront

Cataracts

United States
R. Mark Ghobrial, MD
Novartis

Completed

Myfortic, Prograf, and Corticosteroids in de Novo Liver Transplantation

End Stage Liver Disease

United States
Mark Pimentel, MD
Bausch Health Americas, Inc.

Completed

Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome (C-IBS)

Constipation-predominant Irritable Bowel Syndrome

United States
Kent Wellish MD

Not yet recruiting

Treating Corneal Thinning Conditions With CCL Vario Riboflavin (CXL) (CXL)

Keratoconus, Unstable
Gladwin, Mark, MD
National Institute on Aging (NIA)

Completed

Oral Nitrite for Older Heart Failure With Preserved Ejection Fraction (ONOH)

Heart Failure

United States
Li Zhang, MD

Not yet recruiting

Phase III Study Comparing Osimertinib Monotherapy to Combination Therapy With Osimertinib,Carboplatin and Pemetrexed for Untreated Patients With Advanced Non-squamous Non-Small Cell Lung Cancer With Concurrent EGFR and TP53 Mutations (TOP)

Non-small Cell Carcinoma | EGFR Gene Mutation

China
Eugene F Yen, MD

Recruiting

Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis

Microscopic Colitis

United States
Schmidhofer, Mark, MD
Cystic Fibrosis Foundation; Mast Therapeutics, Inc.

Active, not recruiting

Inhaled Sodium Nitrite as an Antimicrobial for Cystic Fibrosis

Cystic Fibrosis

United States
Li Zhang, MD

Not yet recruiting

JS001 Combination Therapy in NSCLC Negative Driving Gene After First-line Chemotherapy.

Non-small Cell Lung Cancer

China
Li Zhang, MD

Recruiting

An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese

Small Cell Lung Cancer | Lung Cancer | Durvalumab

China
Li Zhang, MD

Recruiting

Ensatinib Treat Second-generation ALK-TKI Resistance After Second-generation ALK-TKI Resistance (ERSGATR)

The Diagnosis Was ALK Positive NSCLC | Second Generation ALK-TKI is Resistant | Efficacy of Ensatinib in This Subset of Patients

China
Li Zhang, MD

Recruiting

Surufatinib Combined With Toripalimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

China
Facteurs Humains en Santé
Dominique FLETCHER MD-PhD; François Marty MD; Dinh Phong Nguyen MD; Loic Druette... and other collaborators

Completed

National French Survey on Psychological Distress at Work of Anesthesia and Intensive Care Residents (PSY-DESAR)

Fatigue | Burnout, Professional | Stress, Psychological | Anesthesia | Depression, Anxiety | Intensive Care | Work Load

France
Gladwin, Mark, MD
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Transfusion of Biotin-Labeled Red Blood Cells

Healthy Volunteers

United States
Mark Pomerantz, MD
Merck Sharp & Dohme LLC; Rainier Therapeutics

Terminated

Ph 1B B-701 in Combination With Pembrolizumab in Metastatic Transitional Cell Carcinoma of the Urothelial Tract

Bladder Cancer

United States
Gladwin, Mark, MD
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE) (SCD-CARRE)

Sickle Cell Disease

United States, France, Brazil
Gladwin, Mark, MD
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (PH-HFpEF)

Heart Failure | Pulmonary Hypertension Secondary

United States
Gladwin, Mark, MD
National Heart, Lung, and Blood Institute (NHLBI)

Completed

A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fraction (PMED)

Heart Failure | Preserved Ejection Fraction | Pulmonary; Hypertension

United States
Mark Packer, MD, FACS
Abbott Medical Optics

Completed

Comparison of Postoperative Visual Acuity and Spectacle Independence Between the Tecnis Multifocal Intraoculer Lens (IOL) and the Crystalens Accommodating IOL

Cataract

United States
Prof. Ziv Ben-Ari MD

Unknown

Using the Non Invasive Technology Magnetic Resonance Elastography for the Diagnosis of Liver Fibrosis Stage

Liver Diseases

Israel
Chen Wei Ren, MD

Unknown

Effects of Glucagon Like Peptide-1 on No-reflow

Acute ST-segment Elevation Myocardial Infarction

China
Dr. Guy Ben-Simon, MD

Completed

Fibrin Glue vs. Suture in Pterygium Surgery

Conjunctival Autograft

Israel
Chen Wei Ren, MD

Unknown

Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury

Acute Myocardial Infarction

China
Prof. Ziv Ben-Ari MD

Unknown

Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases Severity

Fibrosis, Liver | Chronic Liver Disease | Non-Alcoholic Fatty Liver Disease
Mark Garzotto, MD
Merck Sharp & Dohme LLC; Astellas Pharma Inc

Recruiting

Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer

Prostate Cancer

United States
Oana Danciu, MD
Pfizer; Big Ten Cancer Research Consortium

Active, not recruiting

Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer

Metastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive Tumor

United States
Ajjai Alva, MD
AstraZeneca; Big Ten Cancer Research Consortium

Active, not recruiting

Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer

Kidney Cancer | Clear Cell Renal Cell Carcinoma | Advanced Kidney Cancer

United States
Rui-hua Xu, MD, PhD

Not yet recruiting

A Phase II Study of Surufatinib Combined With PD-L1 and mFOLFOX6 as Second-line Treatment for Advanced PRAD

Advanced Pancreatic Cancer

China
Monika Joshi, MD
AstraZeneca

Active, not recruiting

Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder (DUART)

Urothelial Cancer

United States
Gladwin, Mark, MD
National Heart, Lung, and Blood Institute (NHLBI); Complexa, Inc.

Terminated

Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

United States
Patrick Wen, MD
Bristol-Myers Squibb

Active, not recruiting

Surgical Nivolumab And Ipilimumab For Recurrent GBM

Glioblastoma | Glioblastoma Multiforme | GBM | Grade IV Astrocytoma

United States
Gladwin, Mark, MD
National Institutes of Health (NIH); National Institute on Aging (NIA)

Completed

Nitrites, Skeletal Muscle Mitochondrial Bioenergetics, and Physical Activity in Old Age (Nitrite)

Sedentary Lifestyle | Frailty | Aging

United States
Mark Walters, MD
University of California, Berkeley; University of California, Los Angeles

Not yet recruiting

Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease

Sickle Cell Disease

United States
Sacramento EP Research
Padraig Gearoid O'Neill, MD; Mark R. Bowers, MS, MD; Anna M. Thiemann, BA; Shelley... and other collaborators

Completed

Cryoballoon PVI With PWI Versus PVI Alone In Patients With PAF

Paroxysmal Atrial Fibrillation

United States

Clinical Trials Sponsored by Ken Marek, MD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations